Follow on Google News News By Tag * Pharmaceuticals * Biotechnology * Market Research * Medical Devices * Competitive Intelligence * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Pharmaceutical, Healthcare Leaders Seek Innovation and What’s Next at Critical Event in EuropeThe Pharma CI Conference & Exhibition continues to be THE INDUSTRY'S GOLD STANDARD for senior level pharma, biotech, device, and healthcare professionals seeking the latest news, and the rare chance to network with all the industry's luminaries.
By: Pharma CI Conference - Life Cycle Management - Role of CI in Market Access - Social Media - Creating a CI Network - Beyond War Gaming - KOL Mapping - R&D Innovation - Transparency of Clinical Trials - Future of Pharma... and many more critical topics! To view the detailed program agenda, go to: http://pharmaciconference.com/ The 40+ industry experts, who are all part of the talented speaking faculty at the 2014 Pharma CI Europe Conference, come from the most prestigious pharma companies, such as Actavis, Actelion, Astellas, Bausch +Lomb, Bayer Pharma AG, bioMerieux, Celgene, Chiesi Farmaceutici, Debiopharm SA, F. Hoffmann-La Roche Ltd., GE Healthcare, Genomic Health, Gruenenthal GmbH, Helsinn Healthcare S.A., Laboratorios Gebro Pharma, S.A., Lilly, MedImmune, Merck & Co., Inc., Novartis, Orion Pharma, Rivopharm SA, Sanofi, Sanofi Pasteur, Shire, Takeda, Teva, Zambon, and many more! To learn more about the elite speakers, go to: http://pharmaciconference.com/ Healthcare, pharmaceutical, biotechnology, medical devices, and other life sciences professionals all know there is only one place to go to get the latest industry news related to pharmaceutical competitive intelligence. The Pharma CI Europe Conference is THE INDUSTRY'S GOLD STANDARD for senior level pharmaceutical, biotechnology, medical device, and diagnostics professionals seeking the latest news and the industry’s best networking opportunities. For more information, go to http://pharmaciconference.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|